Overview
What you will study
Diabetes management is rapidly evolving. Recent large randomized controlled cardiovascular outcome trials have provided the evidence for the introduction of a variety of new classes of medications available for use for people with type 2 diabetes. Advances in technology including the use of continuous glucose monitoring devices and insulin pumps are improving outcomes for people with type 1 diabetes.
This Diabetes Academy - What's New in Diabetes course offered by University of Melbourne provides an evidence-based update for clinicians on the novel medications and emerging technologies available to improve outcomes in people with diabetes. Clinical case studies using video vignettes and multiple-choice questions are designed to optimise comprehension and learning.
Programme Structure
The program focuses on:
- Essentials of Diabetes Care
- GLP1 Analogues
- SGLT2 Inhibitors
- DPPIV Inhibitors
- Update on Insulin Pump Therapy
- Update on Continuous Glucose Monitoring
- Diabetes in Pregnancy
- Diabetes and Hypertension
- Hyperlipidaemia in Diabetes
- New Insulins
Key information
Duration
- Part-time
- 1 days
Start dates & application deadlines
Language
Delivered
Disciplines
Public Health View 43 other Short Courses in Public Health in AustraliaAcademic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
We are not aware of any English requirements for this programme.
Other requirements
General requirements
- CRICOS: 00116K
- There are no set entry requirements for this course.
Tuition Fee
-
International
550 AUD/fullTuition FeeBased on the tuition of 550 AUD for the full programme during 1 days. -
National
550 AUD/fullTuition FeeBased on the tuition of 550 AUD for the full programme during 1 days.